Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

XORTX Therapeutics Inc (CN: XRX)

 
XRX Technical Analysis
2.5
As on 4th Jan 2022 XRX STOCK Price closed @ 2.64 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.47 & Strong Buy for SHORT-TERM with Stoploss of 1.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

XRXSTOCK Price

Open 2.70 Change Price %
High 2.75 1 Day -0.06 -2.22
Low 2.64 1 Week 0.10 3.94
Close 2.64 1 Month -0.86 -24.57
Volume 2470 1 Year 0.88 50.00
52 Week High 9.04 | 52 Week Low 1.17
 
CN Canada Most Active Stocks
PUMP 0.02 0.00%
CAT 0.03 -25.00%
ACDC 0.06 0.00%
RFR 0.02 0.00%
FMAN 0.55 7.84%
EMER 0.14 -30.00%
TCF 0.36 -5.26%
CURA 5.08 -5.05%
RVV 0.02 -33.33%
TRIP 0.09 0.00%
 
CN Canada Top Gainers Stocks
XCX 0.04 300.00%
ENBI 0.04 100.00%
AION 0.02 100.00%
SILO 0.02 100.00%
SILO 0.02 100.00%
SILO 0.02 100.00%
SPOR 0.07 75.00%
EMRG 0.05 66.67%
MICH 0.13 62.50%
ARGO 0.12 50.00%
 
CN Canada Top Losers Stocks
GTG 0.37 -97.30%
GTG 0.37 -97.30%
TCC 0.04 -55.56%
TCC 0.04 -55.56%
XBLK 0.02 -50.00%
SENS 0.01 -50.00%
SENS 0.01 -50.00%
SENS 0.01 -50.00%
SENS 0.01 -50.00%
SENS 0.01 -50.00%
 
 
XRX
Daily Charts		 XRX
Intraday Charts		 Whats New @
Bazaartrend		 XRX
Free Analysis
 
XRX Important Levels Intraday
RESISTANCE2.85
RESISTANCE2.78
RESISTANCE2.74
RESISTANCE2.70
SUPPORT2.58
SUPPORT2.54
SUPPORT2.50
SUPPORT2.43
 
XRX Forecast May 2024
Share
4th UP Forecast3.64
3rd UP Forecast3.32
2nd UP Forecast3.12
1st UP Forecast2.92
1st DOWN Forecast2.36
2nd DOWN Forecast2.16
3rd DOWN Forecast1.96
4th DOWN Forecast1.64
 
XRX Weekly Forecast
4th UP Forecast4.55
3rd UP Forecast3.94
2nd UP Forecast3.56
1st UP Forecast3.18
1st DOWN Forecast2.10
2nd DOWN Forecast1.72
3rd DOWN Forecast1.34
4th DOWN Forecast0.73
 
XRX Forecast2024
4th UP Forecast19.71
3rd UP Forecast14.24
2nd UP Forecast10.85
1st UP Forecast7.47
1st DOWN Forecast-2.19
2nd DOWN Forecast-5.57
3rd DOWN Forecast-8.96
4th DOWN Forecast-14.43
 
 
XRX Other Details
Segment EQ
Market Capital 39821868.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
XRX Address
XRX
 
XRX Latest News
 
Your Comments and Response on XORTX Therapeutics Inc
 
XRX Business Profile
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada. Address: 745 Thurlow Street, Vancouver, BC, Canada, V6E 0C5
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service